Medical complications and management of lung transplant recipients

Respiratory Care Clinics of North America

Volumn 10, Issue 4, 2004, Pages 505-529

  Arcasoy, Selim M ^a,b  

^a College of Physicians and Surgeons ^*  (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTICOAGULANT AGENT; AZITHROMYCIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RAPAMYCIN; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

BRONCHIOLITIS; BRONCHOSCOPY; CANCER RISK; DISEASE CLASSIFICATION; DISEASE SEVERITY; GRAFT REJECTION; HUMAN; IMMUNOTHERAPY; LUNG BIOPSY; LUNG CARCINOMA; LUNG EMBOLISM; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG SARCOIDOSIS; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; PLEURA EFFUSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE;

ADULT; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PULMONARY FIBROSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 10644290161     PISSN: 10785337     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcc.2004.06.002     Document Type: Review

References (163)

1. E.P. Trulock L.B. Edwards D.O. Taylor M.M. Boucek P.J. Mohacsi B.M. Keck et al. The Registry of the International Society for Heart and Lung Transplantation: Twentieth official adult lung and heart-lung transplant report-2003 J Heart Lung Transplant 22 6 2003 625-635
2. S.M. Arcasoy C. Hersh J.D. Christie D. Zisman A. Pochettino B.R. Rosengard et al. Bronchogenic carcinoma complicating lung transplantation J Heart Lung Transplant 20 10 2001 1044-1053
3. J.R. Maurer S. Tewari Nonpulmonary medical complications in the intermediate and long-term survivor Clin Chest Med 18 2 1997 367-382
4. H.B. Bittner J. Dunitz M. Hertz M.R. Bolman 3rd S.J. Park Hyperacute rejection in single lung transplantation-case report of successful management by means of plasmapheresis and antithymocyte globulin treatment Transplantation 71 5 2001 649-651
5. J.K. Choi J. Kearns H.I. Palevsky K.T. Montone L.R. Kaiser C.M. Zmijewski et al. Hyperacute rejection of a pulmonary allograft. Immediate clinical and pathologic findings Am J Respir Crit Care Med 160 3 1999 1015-1018
6. A.E. Frost C.T. Jammal P.T. Cagle Hyperacute rejection following lung transplantation Chest 110 2 1996 559-562
7. K. Bando I.L. Paradis S. Similo H. Konishi K. Komatsu T.G. Zullo et al. Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management J Thorac Cardiovasc Surg 110 1 1995 4-13
8. J.D. Cooper G.A. Patterson E.P. Trulock Results of single and bilateral lung transplantation in 131 consecutive recipients Washington University Lung Transplant Group J Thorac Cardiovasc Surg 107 2 1994 460-470
9. J.A. Hutter S. Stewart T. Higenbottam J.P. Scott J. Wallwork Histologic changes in heart-lung transplant recipients during rejection episodes and at routine biopsy J Heart Transplant 7 6 1988 440-444
10. S.E. Marshall N.J. Lewiston M.R. Kramer R.K. Sibley G. Berry J.B. Rich et al. Prospective analysis of serial pulmonary function studies and transbronchial biopsies in single-lung transplant recipients Transplant Proc 23 1 Pt 2 1991 1217-1219
11. R.K. Sibley G.J. Berry H.D. Tazelaar M.R. Kraemer J. Theodore S.E. Marshall et al. The role of transbronchial biopsies in the management of lung transplant recipients J Heart Lung Transplant 12 2 1993 308-324
12. E.P. Trulock Lung transplantation Am J Respir Crit Care Med 155 3 1997 789-818
13. E.P. Trulock N.A. Ettinger E.M. Brunt M.K. Pasque L.R. Kaiser J.D. Cooper The role of transbronchial lung biopsy in the treatment of lung transplant recipients. An analysis of 200 consecutive procedures Chest 102 4 1992 1049-1054
14. M.V. Brock M.C. Borja L. Ferber J.B. Orens R.A. Anzcek J. Krishnan et al. Induction therapy in lung transplantation: A prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab J Heart Lung Transplant 20 12 2001 1282-1290
15. P.M. Hopkins C.L. Aboyoun P.N. Chhajed M.A. Malouf M.L. Plit S.P. Rainer et al. Prospective analysis of 1,235 transbronchial lung biopsies in lung transplant recipients J Heart Lung Transplant 21 10 2002 1062-1067
16. S.M. Palmer M.A. Baz L. Sanders A.P. Miralles C.M. Lawrence J.B. Rea et al. Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection Transplantation 71 12 2001 1772-1776
17. S.J. Swanson S.J. Mentzer J.J. Reilly R. Bueno J.M. Lukanich M.T. Jaklitsch et al. Surveillance transbronchial lung biopsies: Implication for survival after lung transplantation J Thorac Cardiovasc Surg 119 1 2000 27-37
18. H. Treede W. Klepetko H. Reichenspurner A. Zuckermann B. Meiser T. Birsan et al. Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols J Heart Lung Transplant 20 5 2001 511-517
19. R.E. Girgis I. Tu G.J. Berry H. Reichenspurner V.G. Valentine J.V. Conte et al. Risk factors for the development of obliterative bronchiolitis after lung transplantation J Heart Lung Transplant 15 12 1996 1200-1208
20. D. Heng L.D. Sharples K. McNeil S. Stewart T. Wreghitt J. Wallwork Bronchiolitis obliterans syndrome: Incidence, natural history, prognosis, and risk factors J Heart Lung Transplant 17 12 1998 1255-1263
21. T.J. Kroshus V.R. Kshettry K. Savik R. John M.I. Hertz R.M. Bolman 3rd Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation J Thorac Cardiovasc Surg 114 2 1997 195-202
22. L.D. Sharples K. McNeil S. Stewart J. Wallwork Risk factors for bronchiolitis obliterans: A systematic review of recent publications J Heart Lung Transplant 21 2 2002 271-281
23. L.D. Sharples M. Tamm K. McNeil T.W. Higenbottam S. Stewart J. Wallwork Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation-early risk factors Transplantation 61 4 1996 560-566
24. A. Le Moine M. Goldman D. Abramowicz Multiple pathways to allograft rejection Transplantation 73 9 2002 1373-1381
25. J. Parkin B. Cohen An overview of the immune system Lancet 357 9270 2001 1777-1789
26. S. Sundaresan Y.G. Alevy N. Steward J. Tucker E.P. Trulock J.D. Cooper et al. Cytokine gene transcripts for tumor necrosis factor-alpha, interleukin-2, and interferon-gamma in human pulmonary allografts J Heart Lung Transplant 14 3 1995 512-518
27. M. Suthanthiran T.B. Strom Immunobiology and immunopharmacology of organ allograft rejection J Clin Immunol 15 4 1995 161-171
28. S. Hasegawa D.M. Ockner J.H. Ritter G.A. Patterson E.P. Trulock J.D. Cooper et al. Expression of class II major histocompatibility complex antigens (HLA-DR) and lymphocyte subset immunotyping in chronic pulmonary transplant rejection Arch Pathol Lab Med 119 5 1995 432-439
29. D.S. Milne A.D. Gascoigne J. Wilkes L. Sviland T. Ashcroft A.J. Malcolm et al. MHC class II and ICAM-1 expression and lymphocyte subsets in transbronchial biopsies from lung transplant recipients Transplantation 57 12 1994 1762-1766
30. S.A. Yousem J.M. Curley J. Dauber I. Paradis H. Rabinowich A. Zeevi et al. HLA-class II antigen expression in human heart-lung allografts Transplantation 49 5 1990 991-995
31. D.B. Badesch M. Zamora D. Fullerton D. Weill R. Tuder F. Grover et al. Pulmonary capillaritis: A possible histologic form of acute pulmonary allograft rejection J Heart Lung Transplant 17 4 1998 415-422
32. C.M. Magro A. Deng A. Pope-Harman W.J. Waldman A. Bernard Collins P.W. Adams et al. Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: A hypothesis Transplantation 74 9 2002 1273-1280
33. C.M. Magro D.M. Klinger P.W. Adams C.G. Orosz A.L. Pope-Harman W.J. Waldman et al. Evidence that humoral allograft rejection in lung transplant patients is not histocompatibility antigen-related Am J Transplant 3 10 2003 1264-1272
34. C.M. Magro A. Pope Harman D. Klinger C. Orosz P. Adams J. Waldman et al. Use of C4d as a diagnostic adjunct in lung allograft biopsies Am J Transplant 3 9 2003 1143-1154
35. E.P. Trulock Management of lung transplant rejection Chest 103 5 1993 1566-1576
36. C.J. Bergin R.A. Castellino N. Blank G.J. Berry R.K. Sibley V.A. Starnes Acute lung rejection after heart-lung transplantation: Correlation of findings on chest radiographs with lung biopsy results AJR Am J Roentgenol 155 1 1990 23-27
37. S. Kundu S.J. Herman A. Larhs D.C. Rappaport G.L. Weisbrod J. Maurer et al. Correlation of chest radiographic findings with biopsy-proven acute lung rejection J Thorac Imaging 14 3 1999 178-184
38. B. Millet T.W. Higenbottam C.D. Flower S. Stewart J. Wallwork The radiographic appearances of infection and acute rejection of the lung after heart-lung transplantation Am Rev Respir Dis 140 1 1989 62-67
39. M.B. Gotway S.K. Dawn D. Sellami J.A. Golden G.P. Reddy F.M. Keith et al. Acute rejection following lung transplantation: Limitations in accuracy of thin-section CT for diagnosis Radiology 221 1 2001 207-212
40. P. Loubeyre D. Revel A. Delignette R. Loire J.F. Mornex High-resolution computed tomographic findings associated with histologically diagnosed acute lung rejection in heart-lung transplant recipients Chest 107 1 1995 132-138
41. B.A. Otulana T. Higenbottam J. Scott C. Clelland G. Igboaka J. Wallwork Lung function associated with histologically diagnosed acute lung rejection and pulmonary infection in heart-lung transplant patients Am Rev Respir Dis 142 2 1990 329-332
42. J.A. Martinez I.L. Paradis J.H. Dauber W. Grgurich T. Richards S.A. Yousem et al. Spirometry values in stable lung transplant recipients Am J Respir Crit Care Med 155 1 1997 285-290
43. H.D. Tazelaar F.N. Nilsson M. Rinaldi P. Murtaugh J.C. McDougall C.G. McGregor The sensitivity of transbronchial biopsy for the diagnosis of acute lung rejection J Thorac Cardiovasc Surg 105 4 1993 674-678
44. S.A. Yousem G.J. Berry E.M. Brunt D. Chamberlain R.H. Hruban R.K. Sibley et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation J Heart Transplant 9 6 1990 593-601
45. S.A. Yousem G.J. Berry P.T. Cagle D. Chamberlain A.N. Husain R.H. Hruban et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection. Lung Rejection Study Group J Heart Lung Transplant 15 1 Pt 1 1996 1-15
46. C. Chaparro D. Chamberlain J. Maurer T. Winton A. Dehoyos S. Kesten Bronchiolitis obliterans organizing pneumonia (BOOP) in lung transplant recipients Chest 110 5 1996 1150-1154
47. J.J. Egan S. Sarker P.S. Hasleton A.A. Woodcock N. Yonan A.K. Deiraniya Should cryptogenic organizing pneumonia be included in the classification of pulmonary allograft rejection? J Heart Lung Transplant 15 12 1996 1268-1269
48. R.A. Guilinger I.L. Paradis J.H. Dauber S.A. Yousem P.A. Williams R.J. Keenan et al. The importance of bronchoscopy with transbronchial biopsy and bronchoalveolar lavage in the management of lung transplant recipients Am J Respir Crit Care Med 152 6 Pt 1 1995 2037-2043
49. S.A. Yousem Significance of clinically silent untreated mild acute cellular rejection in lung allograft recipients Hum Pathol 27 3 1996 269-273
50. C.L. Aboyoun M. Tamm P.N. Chhajed M.A. Malouf P. Hopkins S. Rainer et al. Diagnostic value of follow-up transbronchial lung biopsy after lung rejection Am J Respir Crit Care Med 164 3 2001 460-463
51. B.D. Reams R.D. Davis J. Curl S.M. Palmer Treatment of refractory acute rejection in a lung transplant recipient with campath 1H Transplantation 74 6 2002 903-904
52. H. Shennib G. Massard M. Reynaud M. Noirclerc Efficacy of OKT3 therapy for acute rejection in isolated lung transplantation J Heart Lung Transplant 13 3 1994 514-519
53. H. Shennib M. Mercado D. Nguyen P. Ernst F. Lebel M. O'Donovan et al. Successful treatment of steroid-resistant double-lung allograft rejection with Orthoclone OKT3 Am Rev Respir Dis 144 1 1991 224-226
54. V.G. Valentine R.C. Robbins J.H. Wehner H.R. Patel G.J. Berry J. Theodore Total lymphoid irradiation for refractory acute rejection in heart-lung and lung allografts Chest 109 5 1996 1184-1189
55. J. Villanueva S.M. Bhorade J.A. Robinson A.N. Husain E.R. Garrity Jr. Extracorporeal photopheresis for the treatment of lung allograft rejection Ann Transplant 5 3 2000 44-47
56. B.C. Cahill M.K. O'Rourke K.A. Strasburg K. Savik J. Jessurun R.M. Bolman 3rd et al. Methotrexate for lung transplant recipients with steroid-resistant acute rejection J Heart Lung Transplant 15 11 1996 1130-1137
57. A. Iacono J. Dauber R. Keenan K. Spichty J. Cai W. Grgurich et al. Interleukin 6 and interferon-gamma gene expression in lung transplant recipients with refractory acute cellular rejection: Implications for monitoring and inhibition by treatment with aerosolized cyclosporine Transplantation 64 2 1997 263-269
58. R.J. Keenan A. Iacono J.H. Dauber A. Zeevi S.A. Yousem N.P. Ohori et al. Treatment of refractory acute allograft rejection with aerosolized cyclosporine in lung transplant recipients J Thorac Cardiovasc Surg 113 2 1997 335-340
59. V.G. Valentine R.C. Robbins G.J. Berry H.R. Patel H. Reichenspurner B.A. Reitz et al. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis J Heart Lung Transplant 15 4 1996 371-383
60. A.N. Husain M.T. Siddiqui E.W. Holmes A.J. Chandrasekhar M. McCabe R. Radvany et al. Analysis of risk factors for the development of bronchiolitis obliterans syndrome Am J Respir Crit Care Med 159 3 1999 829-833
61. A. El-Gamel E. Sim P. Hasleton J. Hutchinson N. Yonan J. Egan et al. Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation J Heart Lung Transplant 18 9 1999 828-837
62. M. Estenne M.I. Hertz Bronchiolitis obliterans after human lung transplantation Am J Respir Crit Care Med 166 4 2002 440-444
63. L. Zheng C. Ward G.I. Snell B.E. Orsida X. Li J.W. Wilson et al. Scar collagen deposition in the airways of allografts of lung transplant recipients Am J Respir Crit Care Med 155 6 1997 2072-2077
64. J.L. Billings M.I. Hertz K. Savik C.H. Wendt Respiratory viruses and chronic rejection in lung transplant recipients J Heart Lung Transplant 21 5 2002 559-566
65. R.D. Davis Jr. C.L. Lau S. Eubanks R.H. Messier D. Hadjiliadis M.P. Steele et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation J Thorac Cardiovasc Surg 125 3 2003 533-542
66. M. Estenne J.R. Maurer A. Boehler J.J. Egan A. Frost M. Hertz et al. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria J Heart Lung Transplant 21 3 2002 297-310
67. C.M. Burke J. Theodore K.D. Dawkins S.A. Yousem N. Blank M.E. Billingham et al. Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation Chest 86 6 1984 824-829
68. J.L. Skeens C.R. Fuhrman S.A. Yousem Bronchiolitis obliterans in heart-lung transplantation patients: Radiologic findings in 11 patients AJR Am J Roentgenol 153 2 1989 253-256
69. A.A. Bankier A. Van Muylem C. Knoop M. Estenne P.A. Gevenois Bronchiolitis obliterans syndrome in heart-lung transplant recipients: diagnosis with expiratory CT Radiology 218 2 2001 533-539
70. T. Ikonen L. Kivisaari E. Taskinen A. Piilonen A.L. Harjula High-resolution CT in long-term follow-up after lung transplantation Chest 111 2 1997 370-376
71. E.S. Lee M.B. Gotway G.P. Reddy J.A. Golden F.M. Keith W.R. Webb Early bronchiolitis obliterans following lung transplantation: Accuracy of expiratory thin-section CT for diagnosis Radiology 216 2 2000 472-477
72. W.T. Miller Jr. R.M. Kotloff N.P. Blumenthal J.M. Aronchick W.B. Gefter W.T. Miller Utility of high resolution computed tomography in predicting bronchiolitis obliterans syndrome following lung transplantation: preliminary findings J Thorac Imaging 16 2 2001 76-80
73. M.J. Siegel S. Bhalla F.R. Gutierrez C. Hildebolt S. Sweet Post-lung transplantation bronchiolitis obliterans syndrome: Usefulness of expiratory thin-section CT for diagnosis Radiology 220 2 2001 455-462
74. T. Ikonen L. Kivisaari A.L. Harjula A. Lehtola L. Heikkila V.L. Kinnula et al. Value of high-resolution computed tomography in routine evaluation of lung transplantation recipients during development of bronchiolitis obliterans syndrome J Heart Lung Transplant 15 6 1996 587-595
75. D. Lentz C.J. Bergin G.J. Berry C. Stoehr J. Theodore Diagnosis of bronchiolitis obliterans in heart-lung transplantation patients: importance of bronchial dilatation on CT AJR Am J Roentgenol 159 3 1992 463-467
76. M.R. Kramer C. Stoehr J.L. Whang G.J. Berry R. Sibley S.E. Marshall et al. The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: Low yield of transbronchial lung biopsy J Heart Lung Transplant 12 4 1993 675-681
77. S.A. Yousem I. Paradis B.P. Griffith Can transbronchial biopsy aid in the diagnosis of bronchiolitis obliterans in lung transplant recipients? Transplantation 57 1 1994 151-153
78. S.A. Yousem I.L. Paradis J.H. Dauber B.P. Griffith Efficacy of transbronchial lung biopsy in the diagnosis of bronchiolitis obliterans in heart-lung transplant recipients Transplantation 47 5 1989 893-895
79. H.D. Tazelaar S.A. Yousem The pathology of combined heart-lung transplantation: An autopsy study Hum Pathol 19 12 1988 1403-1416
80. S.A. Yousem C.M. Burke M.E. Billingham Pathologic pulmonary alterations in long-term human heart-lung transplantation Hum Pathol 16 9 1985 911-923
81. J.D. Cooper M. Billingham T. Egan M.I. Hertz T. Higenbottam J. Lynch et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation J Heart Lung Transplant 12 5 1993 713-716
82. R.R. Hachem M.M. Chakinala R.D. Yusen J.P. Lynch A.A. Aloush G.A. Patterson et al. The predictive value of bronchiolitis obliterans syndrome stage 0-p Am J Respir Crit Care Med 169 4 2004 468-472
83. M.B. Anderson J.M. Kriett D.P. Kapelanski A. Perricone C.M. Smith S.W. Jamieson Volume reduction surgery in the native lung after single lung transplantation for emphysema J Heart Lung Transplant 16 7 1997 752-757
84. M.L. Moy S.H. Loring E.P. Ingenito S.J. Mentzer J.J. Reilly Jr. Causes of allograft dysfunction after single lung transplantation for emphysema: Extrinsic restriction versus intrinsic obstruction. Brigham and Women's Hospital Lung Transplantation Group J Heart Lung Transplant 18 10 1999 986-993
85. R. Lazarus D. Sparrow S.T. Weiss Effects of obesity and fat distribution on ventilation function: The normative aging study Chest 111 1997 844-845
86. J.G. Pantoja F.H. Andrade D.S. Stoki A.E. Frost W.L. Eschenbacher M.B. Reid Respiratory and limb muscle function in lung allograft recipients Am J Respir Crit Care Med 160 1999 1205-1211
87. A.R. Glanville J.C. Baldwin C.M. Burke J. Theodore E.D. Robin Obliterative bronchiolitis after heart-lung transplantation: Apparent arrest by augmented immunosuppression Ann Intern Med 107 3 1987 300-304
88. H. Date J.P. Lynch S. Sundaresan G.A. Patterson E.P. Trulock The impact of cytolytic therapy on bronchiolitis obliterans syndrome J Heart Lung Transplant 17 9 1998 869-875
89. D.A. Diamond J.M. Michalski J.P. Lynch E.P. Trulock 3rd Efficacy of total lymphoid irradiation for chronic allograft rejection following bilateral lung transplantation Int J Radiat Oncol Biol Phys 41 4 1998 795-800
90. M. Dusmet J. Maurer T. Winton S. Kesten Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients J Heart Lung Transplant 15 9 1996 948-954
91. S.G. Gerhardt J.F. McDyer R.E. Girgis J.V. Conte S.C. Yang J.B. Orens Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study Am J Respir Crit Care Med 168 1 2003 121-125
92. A.T. Iacono R.J. Keenan S.R. Duncan G.C. Smaldone J.H. Dauber I.L. Paradis et al. Aerosolized cyclosporine in lung recipients with refractory chronic rejection Am J Respir Crit Care Med 153 4 Pt 1 1996 1451-1455
93. B.A. Johnson A.T. Iacono A. Zeevi K.R. McCurry S.R. Duncan Statin use is associated with improved function and survival of lung allografts Am J Respir Crit Care Med 167 9 2003 1271-1278
94. S. Kesten N. Rajagopalan J. Maurer Cytolytic therapy for the treatment of bronchiolitis obliterans syndrome following lung transplantation Transplantation 61 3 1996 427-430
95. A.R. O'Hagan P.C. Stillwell A. Arroliga A. Koo Photopheresis in the treatment of refractory bronchiolitis obliterans complicating lung transplantation Chest 115 5 1999 1459-1462
96. D.J. Ross M.I. Lewis M. Kramer A. Vo R.M. Kass FK 506 'rescue' immunosuppression for obliterative bronchiolitis after lung transplantation Chest 112 5 1997 1175-1179
97. C.T. Salerno S.J. Park N.S. Kreykes D.M. Kulick K. Savik M.I. Hertz et al. Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis J Thorac Cardiovasc Surg 117 6 1999 1063-1069
98. G.I. Snell D.S. Esmore T.J. Williams Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung transplantation Chest 109 4 1996 874-878
99. G.M. Verleden B. Buyse M. Delcroix R. Fabri J. Vanhaecke D. Van Raemdonck et al. Cyclophosphamide rescue therapy for chronic rejection after lung transplantation J Heart Lung Transplant 18 11 1999 1139-1142
100. R.I. Whyte S.J. Rossi M.S. Mulligan R. Florn L. Baker S. Gupta et al. Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantation Ann Thorac Surg 64 4 1997 945-948
101. O. Brugiere G. Thabut Y. Castier H. Mal G. Dauriat A. Marceau et al. Lung retransplantation for bronchiolitis obliterans syndrome: Long-term follow-up in a series of 15 recipients Chest 123 6 2003 1832-1837
102. R.M. Kotloff Lung retransplantation: All for one or one for all? Chest 123 6 2003 1781-1782
103. R.J. Novick L. Stitt Pulmonary retransplantation Semin Thorac Cardiovasc Surg 10 3 1998 227-236
104. R.J. Novick L.W. Stitt K. Al-Kattan W. Klepetko H.J. Schafers J.P. Duchatelle et al. Pulmonary retransplantation: Predictors of graft function and survival in 230 patients. Pulmonary Retransplant Registry Ann Thorac Surg 65 1 1998 227-234
105. E. Konen G.L. Weisbrod S. Pakhale T. Chung N.S. Paul M.A. Hutcheon Fibrosis of the upper lobes: A newly identified late-onset complication after lung transplantation? AJR Am J Roentgenol 181 6 2003 1539-1543
106. J. Collins M.J. Hartman T.F. Warner N.L. Muller E.A. Kazerooni H.P. McAdams et al. Frequency and CT findings of recurrent disease after lung transplantation Radiology 219 2 2001 503-509
107. O. Bjortuft A. Foerster J. Boe O. Geiran Single lung transplantation as treatment for end-stage pulmonary sarcoidosis: Recurrence of sarcoidosis in two different lung allografts in one patient J Heart Lung Transplant 13 1 Pt 1 1994 24-29
108. P. Carre I. Rouquette D. Durand A. Didier M. Dahan G. Fournial et al. Recurrence of sarcoidosis in a human lung allograft Transplant Proc 27 2 1995 1686
109. B.A. Johnson S.R. Duncan N.P. Ohori I.L. Paradis S.A. Yousem W.F. Grgurich et al. Recurrence of sarcoidosis in pulmonary allograft recipients Am Rev Respir Dis 148 5 1993 1373-1377
110. E.A. Kazerooni P.N. Cascade Recurrent miliary sarcoidosis after lung transplantation Radiology 194 3 1995 913
111. E.A. Kazerooni C. Jackson P.N. Cascade Sarcoidosis: Recurrence of primary disease in transplanted lungs Radiology 192 2 1994 461-464
112. F.J. Martinez J.B. Orens M. Deeb L.A. Brunsting A. Flint J.P. Lynch 3rd Recurrence of sarcoidosis following bilateral allogeneic lung transplantation Chest 106 5 1994 1597-1599
113. C. Muller J. Briegel M. Haller C. Vogelmeier I. Bittman A. Welz et al. Sarcoidosis recurrence following lung transplantation Transplantation 61 7 1996 1117-1119
114. M. Yeatman K. McNeil J.A. Smith S. Stewart L.D. Sharples T. Higenbottam et al. Lung Transplantation in patients with systemic diseases: An eleven-year experience at Papworth Hospital J Heart Lung Transplant 15 2 1996 144-149
115. R.C. Cook G. Fradet J.C. English J. Soos N.L. Muller T.P. Connolly et al. Recurrence of intravenous talc granulomatosis following single lung transplantation Can Respir J 5 6 1998 511-514
116. B. Etienne M. Bertocchi J.P. Gamondes F. Thevenet C. Boudard T. Wiesendanger et al. Relapsing pulmonary Langerhans cell histiocytosis after lung transplantation Am J Respir Crit Care Med 157 1 1998 288-291
117. E. Gabbay J.H. Dark T. Ashcroft D. Milne G.J. Gibson M. Healy et al. Recurrence of Langerhans' cell granulomatosis following lung transplantation Thorax 53 4 1998 326-327
118. S.B. Habib J. Congleton D. Carr J. Partridge B. Corrin D.M. Geddes et al. Recurrence of recipient Langerhans' cell histiocytosis following bilateral lung transplantation Thorax 53 4 1998 323-325
119. I. Bittmann T.B. Dose C. Muller H. Dienemann C. Vogelmeier U. Lohrs et al. Lymphangioleiomyomatosis: Recurrence after single lung transplantation Hum Pathol 28 12 1997 1420-1423
120. A. Boehler R. Speich E.W. Russi W. Weder Lung transplantation for lymphangioleiomyomatosis N Engl J Med 335 17 1996 1275-1280
121. J.S. Nine S.A. Yousem I.L. Paradis R. Keenan B.P. Griffith Lymphangioleiomyomatosis: Recurrence after lung transplantation J Heart Lung Transplant 13 4 1994 714-719
122. J.D. O'Brien J.H. Lium J.F. Parosa B.R. Deyoung M.R. Wick E.P. Trulock Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation Am J Respir Crit Care Med 151 6 1995 2033-2036
123. R.I. Garver Jr. G.L. Zorn X. Wu D.C. McGiffin K.R. Young Jr. N.B. Pinkard Recurrence of bronchioloalveolar carcinoma in transplanted lungs N Engl J Med 340 14 1999 1071-1074
124. M.A. Baz P.S. Kussin P. Van Trigt R.D. Davis V.L. Roggli V.F. Tapson Recurrence of diffuse panbronchiolitis after lung transplantation Am J Respir Crit Care Med 151 3 Pt 1 1995 895-898
125. M.B. King J. Jessurun M.I. Hertz Recurrence of desquamative interstitial pneumonia after lung transplantation Am J Respir Crit Care Med 156 6 1997 2003-2005
126. A.E. Frost C.A. Keller R.W. Brown G.P. Noon H.D. Short J.L. Abraham et al. Giant cell interstitial pneumonitis. Disease recurrence in the transplanted lung Am Rev Respir Dis 148 5 1993 1401-1404
127. F. Calabrese C. Giacometti F. Rea M. Loy F. Sartori G. Di Vittorio et al. Recurrence of idiopathic pulmonary hemosiderosis in a young adult patient after bilateral single-lung transplantation Transplantation 74 11 2002 1643-1645
128. L.A. Parker D.B. Novotny Recurrent alveolar proteinosis following double lung transplantation Chest 111 5 1997 1457-1458
129. S. Stewart K. McNeil S.A. Nashef F.C. Wells T.W. Higenbottam J. Wallwork Audit of referral and explant diagnoses in lung transplantation: A pathologic study of lungs removed for parenchymal disease J Heart Lung Transplant 14 6 Pt 1 1995 1173-1186
130. I. Penn Posttransplant malignancies Transplant Proc 31 1-2 1999 1260-1262
131. J.I. Cohen Epstein-Barr virus infection N Engl J Med 343 7 2000 481-492
132. J.M. Armitage R.L. Kormos R.S. Stuart F.J. Fricker B.P. Griffith M. Nalesnik et al. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: Ten years of cyclosporine-based immunosuppression J Heart Lung Transplant 10 6 1991 877-886
133. S.M. Levine L. Angel A. Anzueto I. Susanto J.I. Peters E.Y. Sako et al. A low incidence of posttransplant lymphoproliferative disorder in 109 lung transplant recipients Chest 116 5 1999 1273-1277
134. M.A. Malouf P.N. Chhajed P. Hopkins M. Plit J. Turner A.R. Glanville Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients J Heart Lung Transplant 21 5 2002 547-554
135. S. Paranjothi R.D. Yusen M.D. Kraus J.P. Lynch G.A. Patterson E.P. Trulock Lymphoproliferative disease after lung transplantation: comparison of presentation and outcome of early and late cases J Heart Lung Transplant 20 10 2001 1054-1063
136. D.A. Wigle C. Chaparro A. Humar M.A. Hutcheon C.K. Chan S. Keshavjee Epstein-Barr virus serology and posttransplant lymphoproliferative disease in lung transplantation Transplantation 72 11 2001 1783-1786
137. R.M. Aris D.M. Maia I.P. Neuringer K. Gott S. Kiley K. Gertis et al. Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naive lung transplant recipient Am J Respir Crit Care Med 154 6 Pt 1 1996 1712-1717
138. L.J. Swinnen M.R. Costanzo-Nordin S.G. Fisher E.J. O'Sullivan M.R. Johnson A.L. Heroux et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients N Engl J Med 323 25 1990 1723-1728
139. R.C. Walker C.V. Paya W.F. Marshall J.G. Strickler R.H. Wiesner J.A. Velosa et al. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations J Heart Lung Transplant 14 2 1995 214-221
140. R.R. Hachem M.M. Chakinala R.D. Yusen J.P. Lynch A.A. Aloush G.A. Patterson et al. Abdominal-pelvic lymphoproliferative disease after lung transplantation: Presentation and outcome Transplantation 77 3 2004 431-437
141. P. Hopwood D.H. Crawford The role of EBV in post-transplant malignancies: A review J Clin Pathol 53 4 2000 248-254
142. D.E. Tsai M. Nearey C.L. Hardy J.E. Tomaszewski R.M. Kotloff R.A. Grossman et al. Use of EBV PCR for the diagnosis and monitoring of post-transplant lymphoproliferative disorder in adult solid organ transplant patients Am J Transplant 2 10 2002 946-954
143. D.E. Tsai C.L. Hardy J.E. Tomaszewski R.M. Kotloff K.M. Oltoff B.G. Somer et al. Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: Analysis of prognostic variables and long-term follow-up of 42 adult patients Transplantation 71 8 2001 1076-1088
144. E.A. Verschuuren S.J. Stevens G.W. van Imhoff J.M. Middeldorp C. de Boer G. Koeter et al. Treatment of posttransplant lymphoproliferative disease with rituximab: The remission, the relapse, and the complication Transplantation 73 1 2002 100-104
145. A.G. De Soyza J.H. Dark D.V. Parums A. Curtis P.A. Corris Donor-acquired small cell lung cancer following pulmonary transplantation Chest 120 3 2001 1030-1031
146. E.A. Kazerooni L.C. Chow R.I. Whyte F.J. Martinez J.P. Lynch Preoperative examination of lung transplant candidates: Value of chest CT compared with chest radiography AJR Am J Roentgenol 165 6 1995 1343-1348
147. M.S. Herridge A.L. de Hoyos C. Chaparro T.L. Winton S. Kesten J.R. Maurer Pleural complications in lung transplant recipients J Thorac Cardiovasc Surg 110 1 1995 22-26
148. M.A. Judson J.R. Handy S.A. Sahn Pleural effusion from acute lung rejection Chest 111 4 1997 1128-1130
149. M.A. Judson J.R. Handy S.A. Sahn Pleural effusions following lung transplantation. Time course, characteristics, and clinical implications Chest 109 5 1996 1190-1194
150. T.J. Kroshus V.R. Kshettry M.I. Hertz R.M. Bolman 3rd Deep venous thrombosis and pulmonary embolism after lung transplantation J Thorac Cardiovasc Surg 110 2 1995 540-544
151. S.D. Nathan S.D. Barnett B.A. Urban C. Nowalk B.R. Moran N. Burton Pulmonary embolism in idiopathic pulmonary fibrosis transplant recipients Chest 123 5 2003 1758-1763
152. M.D. Jankowich Idiopathic pulmonary fibrosis in transplantation Chest 124 6 2003 2404
153. K.E. Burns A.T. Iacono Incidence of clinically unsuspected pulmonary embolism in mechanically ventilated lung transplant recipients Transplantation 76 6 2003 964-968
154. D. Hammoud B. Chin False-positive ventilation-perfusion scan in a patient with a transplanted lung Clin Nucl Med 28 6 2003 472-475
155. A.E. Frost C.A. Keller G.P. Noon H.D. Short P.T. Cagle Outcome of the native lung after single lung transplant. Multiorgan Transplant Group Chest 107 4 1995 981-984
156. H. Mal O. Brugiere C. Sleiman I. Rullon G. Jebrak O. Groussard et al. Morbidity and mortality related to the native lung in single lung transplantation for emphysema J Heart Lung Transplant 19 2 2000 220-223
157. H.P. McAdams J.J. Erasmus S.M. Palmer Complications (excluding hyperinflation) involving the native lung after single-lung transplantation: Incidence, radiologic features, and clinical importance Radiology 218 1 2001 233-241
158. G. Speziali J.C. McDougall D.E. Midthun S.G. Peters J.P. Scott R.C. Daly et al. Native lung complications after single lung transplantation for emphysema Transpl Int 10 2 1997 113-115
159. F. Venuta A. Boehler E.A. Rendina T. De Giacomo R. Speich R. Schmid et al. Complications in the native lung after single lung transplantation Eur J Cardiothorac Surg 16 1 1999 54-58
160. D. Weill F. Torres T.N. Hodges J.J. Olmos M.R. Zamora Acute native lung hyperinflation is not associated with poor outcomes after single lung transplant for emphysema J Heart Lung Transplant 18 11 1999 1080-1087
161. N.A. Yonan A. el-Gamel J. Egan J. Kakadellis A. Rahman A.K. Deiraniya Single lung transplantation for emphysema: Predictors for native lung hyperinflation J Heart Lung Transplant 17 2 1998 192-201
162. L.L. Schulman D.P. O'Hair E. Cantu C. McGregor M.E. Ginsberg Salvage by volume reduction of chronic allograft rejection in emphysema J Heart Lung Transplant 18 2 1999 107-112
163. F. Venuta T. De Giacomo E.A. Rendina G. Della Rocca I. Flaishman E. Guarino et al. Thoracoscopic volume reduction of the native lung after single lung transplantation for emphysema Am J Respir Crit Care Med 157 1 1998 292-293